JP2024532964A5 - - Google Patents
Info
- Publication number
- JP2024532964A5 JP2024532964A5 JP2024500491A JP2024500491A JP2024532964A5 JP 2024532964 A5 JP2024532964 A5 JP 2024532964A5 JP 2024500491 A JP2024500491 A JP 2024500491A JP 2024500491 A JP2024500491 A JP 2024500491A JP 2024532964 A5 JP2024532964 A5 JP 2024532964A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- moe
- oligonucleotide
- nucleoside
- complex according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263316905P | 2022-03-04 | 2022-03-04 | |
| US63/316,905 | 2022-03-04 | ||
| PCT/US2022/073536 WO2023283620A1 (en) | 2021-07-09 | 2022-07-08 | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532964A JP2024532964A (ja) | 2024-09-11 |
| JP2024532964A5 true JP2024532964A5 (https=) | 2025-07-15 |
Family
ID=91603709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024500491A Pending JP2024532964A (ja) | 2022-03-04 | 2022-07-08 | 筋標的化複合体および筋緊張性ジストロフィーを処置するためのその使用 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP2024532964A (https=) |
| CN (1) | CN118265724A (https=) |
-
2022
- 2022-07-08 JP JP2024500491A patent/JP2024532964A/ja active Pending
- 2022-07-08 CN CN202280060779.9A patent/CN118265724A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024503609A5 (https=) | ||
| IL309910A (en) | Muscle targeting complexes and their uses for the treatment of myotonic dystrophy | |
| JP2024524222A5 (https=) | ||
| JP2025512468A5 (https=) | ||
| JP2023510350A5 (https=) | ||
| JP2023509793A5 (https=) | ||
| JP2023510351A5 (https=) | ||
| US20260069704A1 (en) | Muscle targeting complexes and formulations for treating myotonic dystrophy | |
| JP2023512441A5 (https=) | ||
| US20250249116A1 (en) | Muscle targeting complexes and uses thereof for treating myotonic dystrophy | |
| JP2024501872A5 (https=) | ||
| CN110753756B (zh) | 免疫调节性多核苷酸及其应用 | |
| JP2023535078A5 (https=) | ||
| JP2025512469A5 (https=) | ||
| JP2024525611A5 (https=) | ||
| CN115427458A (zh) | 转谷氨酰胺酶介导的缀合 | |
| JP2024534488A5 (https=) | ||
| IL312170A (en) | Muscle targeting complexes for treating facioscapulohumeral muscular dystrophy | |
| JP2021532831A5 (https=) | ||
| JP2021533199A5 (https=) | ||
| IL316206A (en) | Dosage of muscle targeting complexes for the treatment of myotonic dystrophy | |
| JP2024525612A5 (https=) | ||
| JP2024546436A5 (https=) | ||
| CN107428813A (zh) | 组合肿瘤免疫疗法 | |
| JP2026503873A (ja) | Ｄｍｄ遺伝子のエクソン４５をスキップするための筋肉標的化複合体およびその使用 |